Private Equity’s New Play in Medtech
Private equity buyers have jumped into the medical device sector in 2025, flush with capital and plans for revamping companies in an unforgiving, volatile macroenvironment. Blackstone and TPG’s take out of publicly traded Hologic is a high-profile example of the opportunity.
Read Article